Program
DAY 1 / Sep. 19(Fri), 2025
Moderator: Jong Wook KIM (Korea)
| Time | Program | Chair / Speaker |
|---|---|---|
| 12:00-13:00 | Lunch | |
| 13:00-13:20 | Welcome Remarks | Jae-Young JOUNG (Korea) (President, KPS) |
| Ji Youl LEE (Korea) (President, APSU) |
||
| Seong Il SEO (Korea) (President, KUA) |
||
| 13:20-14:50 | Session I: Prostate Cancer I (Screening & Biopsy): Changing Paradigms | Seong Il SEO (Korea) |
| Seok Joong YUN (Korea) | ||
| Takashi FUKAGAI (Japan) | ||
| 13:20-13:30 | National health strategies to the sharp rise in prostate cancer incidence | Young Hwii KO (Korea) |
| 13:30-13:40 | What is the optimal approach to prostate cancer screening? MRI first or PSA first | Won Hoon SONG (Korea) |
| 13:40-14:00 | Rethinking Prostate Biopsy in the PSA Screening Era: Toward Precision and Individualization | Ilker TINAY (Türkiye) |
| 14:00-14:10 | Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection | Dongho SHIN (Korea) |
| 14:10-14:20 | Role of lesional and perilesional sampling in patients undergoing prostate biopsies : are standard biopsies necessary? | Sang Wook LEE (Korea) |
| 14:20-14:50 | Panel Discussion | Tae Hyo KIM (Korea) |
| Jong Hyun YOON (Korea) | ||
| Won Tae KIM (Korea) | ||
| Jae Heon KIM (Korea) | ||
| Bannakij LOJANAPIWAT (Thailand) | ||
| 14:50-15:10 | Satellite Symposium sponsored by Novartis | Ji Youl LEE (Korea) |
| 14:50-15:10 | From VISION to Real-World: Practical Insights on Implementing PSMA Radioligand Therapy | Frédéric POULIOT (Canada) |
| 15:10-15:40 | Coffee Break / Visit Exhibits | |
| 15:40-17:30 | Session II: Prostate Cancer II (Locally advanced disease): Navigating Treatment Strategies | Sung Kyu HONG (Korea) |
| Jun Sung KOH (Korea) | ||
| Takahiro KIMURA (Japan) | ||
| 15:40-16:00 | The comparison of outcomes between neoadjuvant novel and classic hormonal therapy in patients with locally advanced prostate cancer | Bertrand Tombal (Belgium) |
| 16:00-16:20 | Locally advanced Prostate Cancer: Navigating Controversies in Radiation and Surgical Strategies | Fumihiko URABE (Japan) |
| 16:20-16:40 | Medical treatment in high-risk localised or locally advanced prostate cancer | Amit BAHL (UK) |
| 16:40-17:00 | Managing prostate cancer patients with PSA persistence after RP | Takahiro INOUE (Japan) |
| 17:00-17:30 | Case Discussion | Moderator: Seong Hyeon YU (Korea) |
| Soodong KIM (Korea) | ||
| Hongzoo PARK (Korea) | ||
| Jae Hyun RYU (Korea) | ||
| Kuan Chou CHEN (Taiwan) | ||
| Joseph KIM (USA) | ||
| 17:30 | Welcome Dinner | |
DAY 2 / Sep. 20(Sat), 2025
Moderator: Jong Wook KIM (Korea)
| Time | Program | Chair / Speaker |
|---|---|---|
| 09:30-10:20 | Session III: Prostate Cancer III (Surgery & Focal Therapy): Precision and Innovation | Moon Ki JO (Korea) |
| Kyung Hyun MOON (Korea) | ||
| 09:30-09:37 | Sparing the periprostatic neurovascular bundles during robot-assisted radical prostatectomy (RARP) | Dalsan YOU (Korea) |
| 09:37-09:44 | Next generation robot-assisted surgery (RAS) platform | See Min CHOI (Korea) |
| 09:44-09:51 | New options of prostate focal therapy | Hakmin LEE (Korea) |
| 09:51-09:58 | Cytoreductive Prostatectomy in the management of men with oligometastatic prostate cancer | Hee Jo YANG (Korea) |
| 09:58-10:20 | Case Discussion | Moderator: Hyung Joon KIM (Korea) |
| Hoon CHOI (Korea) | ||
| In Chang CHO (Korea) | ||
| Lukman HAKIM (Indonesia) | ||
| Takashi FUKAGAI (Japan) | ||
| 10:20-10:40 | Commemorative Photo & Coffee Break / Visit Exhibits | |
| 10:40-11:50 | Session IV: Urothelial Cancer: From Biomarkers to Clinical Decision Making | Ho Kyung SEO (Korea) |
| Jae Seung CHUNG (Korea) | ||
| Kuan Chou CHEN (Taiwan) | ||
| 10:40-11:00 | High grade non muscle invasive urothelial carcinoma - what's the next step? | Ilker TINAY (Türkiye) |
| 11:00-11:07 | MIBC Treatment Decisions: Role of ctDNA, utDNA, and Timing of Radical Cystectomy | Kyung Hwan KIM (Korea) |
| 11:07-11:14 | Post-NAC cT0: Still Indication for Radical Cystectomy | Geehyun SONG (Korea) |
| 11:14-11:21 | Bladder Cancer After UTUC: Contemporary Risk and Management Review | Jong Kil NAM (Korea) |
| 11:21-11:50 | Case Discussion | Moderator: Joongwon CHOI (Korea) |
| Byung Hoon KIM (Korea) | ||
| Jung Ki JO (Korea) | ||
| TBD | ||
| 11:50-12:50 | Luncheon Symposium sponsored by Janssen | Jae Young PARK (Korea) |
| 11:50-12:10 | Evidenced-based Use of AR Pathway inhibitor for Advanced prostate cancer | Joseph KIM (USA) |
| 12:10-12:50 | Lunch | |
| 12:50-14:30 | Session V: Prostate Cancer IV (mHSPC): Biomarkers, Intensification, and De-escalation Debate | Jae Il CHUNG (Korea) |
| Hwang Gyun JEON (Korea) | ||
| Bannakij LOJANAPIWAT (Thailand) | ||
| 12:50-12:57 | Importance of early genetic testing in metastatic prostate cancer | Yong Hyun PARK (Korea) |
| 12:57-13:17 | Treatment optimisation in mHSPC | Amit BAHL (UK) |
| 13:17-13:37 | Drug Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Current Evidence and Future Perspectives | Fumihiko URABE (Japan) |
| 13:37-14:02 | mHSPC with deep response to ADT plus ARPI | |
| 13:37-13:47 | 1, Contra de-escalation | Yun Sok HA (Korea) |
| 13:47-14:02 | 2, Pro de-escalation | Takahiro KIMURA (Japan) |
| 14:02-14:30 | Case Discussion | Moderator: Sang Hun SONG (Korea) |
| Jongwook PARK (Korea) | ||
| Ho Young BAE (Korea) | ||
| TBD | ||
| 14:30-14:50 | Satellite Symposium sponsored by Astellas | Tag Keun YOO (Korea) |
| 14:30-14:50 | My Practice with Harnal & Betmiga | Jae Heon KIM (Korea) |
| 14:50-15:10 | Coffee Break / Visit Exhibits | |
| 15:10-16:50 | Session VI: Prostate Cancer V (mCRPC): Sequencing, Theranostics, and the Future | Taek Won KANG (Korea) |
| U-Syn HA (Korea) | ||
| Lukman HAKIM (Indonesia) | ||
| 15:10-15:30 | Modern Sequencing and Intensification Strategies in mCRPC: From Guidelines to Genomics | Bertrand TOMBAL (Belgium) |
| 15:30-15:37 | Navigating therapeutic sequencing in mCRPC: PARPi and systemic therapy | Bum Sik TAE (Korea) |
| 15:37-15:57 | Advancing the utilization of PET imaging for staging and PSMA Theranostics: Role of PSMA and FDG PET Radiomics to Predict Treatment Response | Frédéric POULIOT (Canada) |
| 15:57-16:17 | PSMA targeted α-radiation therapy: Recent advances and future perspectives | Yoshiyuki KOJIMA (Japan) |
| 16:17-16:50 | Case discussion | Moderator: Se Young CHOI (Korea) |
| Seyun KWON (Korea) | ||
| Sangchul LEE (Korea) | ||
| TBD | ||
| 16:50-17:00 | Closing Remarks | Jae Young JOUNG (Korea) |
| 17:00 | Banquet | |
Copyright(C) by 2025 KPS in conjunction with APSU Joint International Symposium.
All rights reserved.
Secretariat of KPS
Gaon Convention Services, Inc.
ADDRESS: ROOM 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989 | E-MAIL : gaonpco@gaonpco.com